Skip to main content

What the FDA labels say about taking them together

Fexinidazole and metronidazole

Fexinidazole's FDA label of May 2, 2025 names metronidazole in its contraindications section; the metronidazole labels PlainMeds reads (4) do not name fexinidazole. The fexinidazole label: “CONTRAINDICATIONS Fexinidazole Tablets are contraindicated in: Patients with known hypersensitivity to Fexinidazole Tablets and/or any nitroimidazole-class drugs.”

Check it at the source: the fexinidazole FDA label on DailyMed (effective May 2, 2025, Sanofi-Aventis U.S. LLC); the metronidazole FDA label on DailyMed (effective September 3, 2024, Aurobindo Pharma Limited).

What does the fexinidazole label say about metronidazole?

Fexinidazole label, contraindications

CONTRAINDICATIONS Fexinidazole Tablets are contraindicated in: Patients with known hypersensitivity to Fexinidazole Tablets and/or any nitroimidazole-class drugs (e.g., metronidazole, tinidazole).

Source: FDA drug label (Fexinidazole), Sanofi-Aventis U.S. LLC, effective May 2, 2025 (SPL set 74a611bc-9977-46bb-b626-0370b3031628), via openFDA; the full label on DailyMed

What does the metronidazole label say about fexinidazole?

Metronidazole's label (effective September 3, 2024) and its 3 other brand-application labels do not name fexinidazole in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (Metronidazole), Aurobindo Pharma Limited, effective September 3, 2024 (SPL set f68397ee-67db-472e-8607-4300064e37df), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

0Fexinidazole generic labelers
55Metronidazole generic labelers
FexinidazoleMetronidazole
Labeled forn/aBacterial infections
Boxed warningNoYes
Pharmacy cost (NADAC)n/a$0.102 per tablet 250 mg tablet
Shortage nowNo current entryIn shortage

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?